Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Department of Anesthesia, First Hospital of Jilin University, Changchun, China.
FASEB J. 2018 Aug;32(8):4284-4292. doi: 10.1096/fj.201701069R. Epub 2018 Mar 9.
Ubiquitin E3 ligases mediate ubiquitination and degradation of intracellular proteins. We have shown that a relatively new Skp, Cullin, F-box (SCF) protein E3 ligase, SCF FBXL19, has an anti-inflammatory effect and controls actin cytoskeleton dynamics via targeting cell membrane receptor and small GTPases for their ubiquitination and degradation, but the molecular regulation of its subunit FBXL19 stability remains unclear. Here we show that FBXL19 degradation is controlled by the balance between its ubiquitination and acetylation. FBXL19 is an unstable protein with a half-life of ∼3 h. FBXL19 can be polyubiquitinated, and the proteasome inhibitor MG-132 prolongs FBXL19 half-life, suggesting that FBXL19 degradation is mediated in the ubiquitin-proteasome system. FBXL19 can also be acetylated, and enhancing acetylation of FBXL19 by a deacetylase inhibitor reduces FBXL19 ubiquitination levels. Acetylation-mimic FBXL19 mutant exhibits a longer half-life than wild type. An acetyltransferase CBP catalyzes acetylation of FBXL19. Inhibition or down-regulation of CBP reduces FBXL19 stability, whereas it is increased in CBP-overexpressing cells. Taken together, the data indicate that CBP-mediated acetylation reduces ubiquitination and stabilizes FBXL19. Further, we demonstrate that FBXL19 targets small GTPase Cdc42 for its ubiquitination and degradation, whereas this effect is reversed by inhibition of CBP, suggesting that CBP increases the effect of SCF FBXL19 E3 ligase through acetylation and stabilization of FBXL19. Our study reveals a new molecular model for regulation of SCF E3 ligase function by acetylation and stabilization of its subunit F-box protein.-Wei, J., Dong, S., Yao, K., Martinez, M. F. Y. M., Fleisher, P. R., Zhao, Y., Ma, H., Zhao, J. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
泛素 E3 连接酶介导细胞内蛋白质的泛素化和降解。我们已经表明,一种相对较新的 Skp、Cullin、F-box(SCF)蛋白 E3 连接酶 SCF FBXL19 具有抗炎作用,并通过靶向细胞膜受体和小 GTP 酶来控制肌动蛋白细胞骨架的动态,从而促进其泛素化和降解,但它的亚基 FBXL19 稳定性的分子调控尚不清楚。在这里,我们表明 FBXL19 的降解是由其泛素化和乙酰化之间的平衡控制的。FBXL19 是一种不稳定的蛋白质,半衰期约为 3 小时。FBXL19 可以被多泛素化,蛋白酶体抑制剂 MG-132 延长 FBXL19 的半衰期,表明 FBXL19 的降解是通过泛素-蛋白酶体系统介导的。FBXL19 也可以被乙酰化,并且去乙酰化酶抑制剂增强 FBXL19 的乙酰化会降低 FBXL19 的泛素化水平。乙酰化模拟 FBXL19 突变体的半衰期比野生型长。乙酰转移酶 CBP 催化 FBXL19 的乙酰化。抑制或下调 CBP 会降低 FBXL19 的稳定性,而在 CBP 过表达的细胞中则会增加。总之,这些数据表明 CBP 介导的乙酰化减少了泛素化并稳定了 FBXL19。此外,我们证明 FBXL19 靶向小 GTPase Cdc42 进行泛素化和降解,而 CBP 的抑制则逆转了这种作用,这表明 CBP 通过乙酰化和稳定 FBXL19 来增加 SCF FBXL19 E3 连接酶的作用。我们的研究揭示了一种新的分子模型,即通过其亚基 F 盒蛋白的乙酰化和稳定来调节 SCF E3 连接酶的功能。